Total debt fell to $6.0M and the debt-to-equity ratio to 0.76, but cash declined from $36.8M to $25.1M over two quarters while the current ratio dropped to 0.90, suggesting liquidity pressure may be building.
LifeMD, Inc. (LFMD) balance sheet — 15-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Total Current Assets | 49.26M | 51.83M | 48.73M | 42.6M | 11.31M | 44.92M | 12.41M | 2.75M | 1.61M | 1.26M | 789.82K | 448.47K | 131.47K | 450.73K | 212K | 128.66K |
| Cash & Short-Term Investments | 21.92M | 36.79M | 35M | 33.15M | 3.96M | 41.33M | 9.18M | 1.11M | 180.09K | 141.38K | 182.56K | 232.98K | 75.5K | 155.06K | 98.93K | 33.5K |
| Cash Only | 21.92M | 36.79M | 35M | 33.15M | 3.96M | 41.33M | 9.18M | 1.11M | 180.09K | 141.38K | 182.56K | 232.98K | 75.5K | 155.06K | 98.93K | 33.5K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 13.25M | 9.31M | 8.22M | 5.28M | 2.83M | 980.05K | 997.76K | 97.45K | 99.05K | 128.19K | 446.99K | 154.44K | 14.97K | 209.47K | 49.69K | 36.36K |
| Days Sales Outstanding | 21.21 | 17.5 | 14.12 | 12.63 | 8.69 | 3.85 | 9.77 | 2.85 | 4.34 | 9.26 | 31.14 | 46.25 | 7.65 | 94.58 | 26.92 | 17.84 |
| Inventory | 10.35M | 2.77M | 2.8M | 2.76M | 3.7M | 1.62M | 1.26M | 950.06K | 1.02M | 707.16K | 160.27K | 61.05K | 41.01K | 86.19K | 63.38K | 58.8K |
| Days Inventory Outstanding | 59.25 | 25.76 | 42.42 | 53.3 | 72.41 | 32.79 | 52.08 | 137.32 | 189.56 | 173.97 | 30.06 | 89.94 | 86.59 | 173.53 | 184.15 | 88.96 |
| Other Current Assets | 3.52M | 2.65M | 2.67M | 934.51K | 687.02K | 793.19K | 154.88K | 442.97K | 270.01K | 296.48K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 17.02M | 18.58M | 23.73M | 15.88M | 14.35M | 5M | 990.26K | 699.08K | 1.01M | 0 | 0 | 0 | 43.75K | 100.72K | 157.7K | 214.67K |
| Property, Plant & Equipment | 6.53M | 5.27M | 7.88M | 1.07M | 1.68M | 1.99M | 274.44K | 23.63K | 0 | 0 | 0 | 0 | 43.75K | 100.72K | 157.7K | 214.67K |
| Fixed Asset Turnover | 31.85x | 36.84x | 26.96x | 142.41x | 70.75x | 46.76x | 135.89x | 527.77x | - | - | - | - | 16.32x | 8.03x | 4.27x | 3.46x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.5M | 262.33K | 15.85M | 14.81M | 12.67M | 3.02M | 715.82K | 675.45K | 1.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 13.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -157.7K | 0 |
| Total Assets | 66.29M | 70.41M | 72.46M | 58.48M | 25.67M | 49.92M | 13.4M | 3.45M | 2.62M | 1.26M | 789.82K | 448.47K | 175.22K | 551.45K | 369.69K | 343.33K |
| Asset Turnover | 2.83x | 2.76x | 2.93x | 2.61x | 4.64x | 1.86x | 2.78x | 3.62x | 3.18x | 4.00x | 6.63x | 2.72x | 4.08x | 1.47x | 1.82x | 2.17x |
| Asset Growth % | -25.7% | -2.83% | 23.9% | 127.85% | -48.59% | 272.48% | 288.92% | 31.73% | 107% | 60.01% | 76.11% | 155.95% | -68.23% | 49.16% | 7.68% | - |
| Total Current Liabilities | 61.7M | 41.57M | 60.26M | 34.78M | 31.37M | 22.83M | 13.93M | 3.98M | 1.19M | 640.97K | 1.15M | 267.48K | 301.52K | 325.56K | 187.1K | 561.51K |
| Accounts Payable | 37.74M | 14.15M | 16.01M | 11.08M | 10.11M | 9.06M | 10.41M | 3M | 869K | 473.49K | 752.93K | 167.48K | 141.32K | 185.36K | 187.1K | 199.34K |
| Days Payables Outstanding | 282.18 | 131.43 | 242.78 | 214.07 | 197.61 | 183.75 | 428.72 | 433.34 | 161.08 | 116.48 | 141.22 | 246.72 | 298.42 | 373.17 | 543.63 | 301.58 |
| Short-Term Debt | 0 | 0 | 8.44M | 327.6K | 2.8M | 63.4K | 779.13K | 814.73K | 247.42K | 167.48K | 206.37K | 100K | 27.2K | 40.2K | 0 | 262.17K |
| Deferred Revenue (Current) | 44.05M | 10.81M | 14.48M | 8.83M | 5.55M | 1.5M | 916.88K | 0 | 75.98K | -473.49K | 0 | -167.48K | -274.32K | -40.2K | 0 | 0 |
| Other Current Liabilities | 0 | 2.41M | 5.11M | 3M | 576.03K | 1.66M | 237.04K | 109.55K | -869K | -422.35K | -560.68K | -167.48K | 133K | 0 | 0 | 0 |
| Current Ratio | 0.80x | 1.25x | 0.81x | 1.22x | 0.36x | 1.97x | 0.89x | 0.69x | 1.35x | 1.97x | 0.69x | 1.68x | 0.44x | 1.38x | 1.13x | 0.23x |
| Quick Ratio | 0.63x | 1.18x | 0.76x | 1.15x | 0.24x | 1.90x | 0.80x | 0.45x | 0.49x | 0.87x | 0.55x | 1.45x | 0.30x | 1.12x | 0.79x | 0.12x |
| Cash Conversion Cycle | -201.71 | -88.16 | -186.24 | -148.14 | -116.51 | -147.11 | -366.88 | -293.17 | 32.82 | 66.74 | -80.01 | -110.54 | -204.17 | -105.06 | -332.56 | -194.78 |
| Total Non-Current Liabilities | 5.16M | 5.68M | 16.25M | 18.13M | 1.6M | 1.28M | 292.32K | 599.98K | 604K | 0 | 0 | 0 | 13.2K | 30.4K | 47.6K | 64.8K |
| Long-Term Debt | 0 | 0 | 9.89M | 17.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 16.16M | 5.68M | 6.27M | 73.85K | 574.14K | 1.18M | 192.32K | 29.98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 13.2K | 30.4K | 47.6K | 64.8K |
| Other Non-Current Liabilities | 0 | 0 | 100K | 131.25K | 1.02M | 100K | 100K | 570K | 600K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 66.86M | 47.25M | 76.51M | 52.91M | 32.97M | 24.1M | 14.22M | 4.58M | 1.8M | 640.97K | 1.15M | 267.48K | 314.72K | 355.96K | 234.7K | 626.31K |
| Total Debt | 5.85M | 6.32M | 25.1M | 18.93M | 4.13M | 1.85M | 1.06M | 844.71K | 247.42K | 167.48K | 206.37K | 100K | 27.2K | 40.2K | 0 | 262.17K |
| Net Debt | -16.07M | -30.46M | -9.9M | -14.21M | 168.52K | -39.48M | -8.11M | -261.91K | 67.32K | 26.1K | 23.8K | -132.98K | -48.3K | -114.86K | -98.93K | 228.67K |
| Debt / Equity | -10.10x | 0.27x | - | 3.40x | - | 0.07x | - | - | 0.30x | 0.27x | - | 0.55x | - | 0.21x | - | - |
| Debt / EBITDA | -0.43x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 1.18x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -6692.61x | -6.48x | -7.40x | -5.71x | -31.10x | -19.31x | -34.67x | -3.80x | -5.80x | -12.72x | -24.16x | -3.60x | -101.00x | -83.33x | -136.30x | -23.46x |
| Total Equity | -579.65K | 23.16M | -4.05M | 5.57M | -7.31M | 25.82M | -821.76K | -1.13M | 819.74K | 622.84K | -361.73K | 180.99K | -139.5K | 195.49K | 135K | -282.98K |
| Equity Growth % | 6467.17% | 672.42% | -172.68% | 176.19% | -128.29% | 3241.91% | 27.23% | -237.76% | 31.61% | 272.19% | -299.86% | 229.74% | -171.36% | 44.81% | 147.71% | - |
| Book Value per Share | -0.01 | 0.51 | -0.10 | 0.16 | -0.24 | 0.96 | -0.06 | -0.11 | 0.09 | 0.07 | -0.05 | 0.03 | -0.02 | 0.03 | 0.02 | -0.04 |
| Total Shareholders' Equity | -579.65K | 23.16M | -5.49M | 3.51M | -6.83M | 26.85M | 1.35M | -988.18K | 897.7K | 881.92K | -355.17K | 100.08K | -139.5K | 195.49K | 135K | -282.98K |
| Common Stock | 483.59K | 467.6K | 422.94K | 383.59K | 315.53K | 307.05K | 234.34K | 106.81K | 457.82K | 444.93K | 355.7K | 320.1K | 307.3K | 301.05K | 289.1K | 247.29K |
| Retained Earnings | -256.34M | -228.6M | -236.25M | -214.27M | -190.56M | -141.92M | -80.15M | -16.59M | -12.14M | -10.9M | -9.69M | -8.59M | -8.52M | -8.06M | -7.8M | -7.35M |
| Treasury Stock | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -163.7K | -87.05K | 0 | 0 | 0 | 0 | -51.83K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -679.29K | -635.54K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 1.44M | 2.06M | -475.55K | -1.03M | -2.18M | -141.06K | -77.96K | -259.08K | -6.55K | 80.91K | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying LFMD stock.
As of 2025, LifeMD, Inc. (LFMD) had total assets of $70.4M including $51.8M in current assets.
LifeMD, Inc. (LFMD) carries total debt of $6.3M, offset by $36.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
LifeMD, Inc. (LFMD) has total shareholders' equity (book value) of $23.2M ($0.51 book value per share). Book value represents the net worth of the company belonging to common stock holders.
LifeMD, Inc. (LFMD) reported a current ratio of 1.25x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Shrinking equity and cash erosion
Metrics are mathematically derived from official filings.
Equity Rebuilt From Deep Deficit
Based on LifeMD's reported figures, shareholders' equity swung from a deficit of $7.7M in 2024Q3 to $23.2M in 2025Q4 before falling back to $8.0M in 2026Q2, signaling that the balance sheet recovery has partly reversed.
The move into positive equity during late 2025 appears driven by the sharp reduction in total liabilities from $73.2M to $47.3M, likely reflecting debt repayment and a shrinking liability base rather than operating earnings. The subsequent decline in equity alongside a $10.6M fall in total assets from 2025Q4 to 2026Q2 suggests the improvement may not be durable. Investors should monitor whether asset contraction continues to outpace liability reduction.
Leverage Normalized but Liquidity Thinning
Per reported balance sheet data, total debt fell from $25.1M in early 2025 to $6.0M in 2026Q2, lowering the debt-to-equity ratio to 0.76, yet cash declined from $36.8M to $25.1M over two quarters.
The reduction in debt materially lowers refinancing risk, which is a constructive development for a company with thin equity. However, the pattern of retiring obligations while cash balances decline suggests the deleveraging was funded from the company's own reserves rather than from recurring cash generation. The quarter-to-quarter D/E swings from 0.27 to 0.76 indicate that headline leverage figures are sensitive to small equity changes and should be read with caution.
Current Ratio Slips Below Parity
According to reported financial statements, LifeMD's current ratio fell from 1.25 in 2025Q4 to 0.90 in 2026Q2, placing current liabilities above current assets for the first time in the displayed period.
A current ratio below 1.0 means short-term obligations exceed liquid resources, which warrants closer attention given that cash fell by roughly $11.7M over the same two quarters. Cash of $25.1M still provides a meaningful buffer against near-term obligations, but the trajectory implies that continued operating losses would erode this cushion. The business appears to depend on sustained cash preservation to maintain its current position.
Accumulated Deficit Dwarfs Equity Base
Based on LifeMD's reported figures, retained earnings stood at negative $246.1M in 2026Q2, roughly thirty times the $8.0M of total equity, reflecting a long history of cumulative losses.
The scale of the accumulated deficit indicates that the current positive equity is the product of paid-in capital rather than retained profits. Reported stock-based compensation of $2.1M to $4.2M per quarter continues to add to paid-in capital, which may dilute existing holders over time. Investors should weigh whether the equity base can absorb further losses without requiring additional capital raises.
Goodwill Collapse Obscures Asset Quality
As reported in the financial statements, goodwill fell from $16.7M in 2025Q2 to $198.5K in 2026Q2, a reduction that may reflect impairment and substantially reshapes the reported asset base.
A near-complete write-down of goodwill can make the remaining asset base appear cleaner, but it also signals that acquired value has been reassessed sharply lower. The reduction in total assets is therefore partly non-operational, which complicates comparisons of underlying performance. Whether the impairment reflects a broader reassessment of acquired businesses warrants further investigation through the filings.